Research Groups: Criteria for ESPT Membership

The strong linkage between Research Teams, Research Groups working in the field and ESPT will represent the scientific image of our organization.

 The Research groups representing one or two domains important for Pharmacogenomics and Personalized Medicine:

  • Will be put with the best possible visibility on our Web site and in documents. The activities of the research group will be described shortly on the web with the updated publications of the members
  • The group is constituted of a leader, who have to be ESPT full member and 10-30 associate members 

All members have full access to all ESPT activities (Restricted area on the ESPT web site (DMPT, teaching platform) and Reductions for courses, schools and meetings)

  • The members particularly the young members will be strongly associated with the scientific activities of ESPT (Annual meetings)
  • They could participate and propose new committees. This strategy will support also dynamically the carriers of young co-workers

The annual membership fee (2014 and 2015): 20 € per Associate member and 100 € for the leader(s)

 

Research Groups

For more information about the research group, please click on the name of the group.

Name

Location

Contact

Number of Members

Extremadura University Hospital and Medical School, Badajoz - CICAB Clinical Research Center

Badajoz, Spain

Adrian Llerena

13

University of Ljubljana, Faculty of Pharmacy research group

Ljubljana, Slovenia

Janja Marc

11

UMR INSERM U 1122 Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV) 

Nancy, France

Sophie Siest

10

Labex –Institut de Biologie de Lille – CNRS UMR 8199

Lille, France

Philippe Froguel

17

Karolinska Institute – Department of Physiology and Pharmacology

Stockholm,Sweden

Magnus Ingelman-Sundberg

5

Pharmacogenetics Research Group Rotterdam

Rotterdam, The Netherlands

Ron H.N. Van Schaik

8

Pharmacogenomics laboratory - Research Center CHUQ (CHUL) – Laval University Faculty of Pharmacy

Quebec, Canada

Chantal Guillemette

11

Laboratoire d’hématologie – CHU Timone

Marseille, France

Pierre Morange / Marie-Christine Alessi

6

Lab Applied Molecular Biology and Pharmacogenomics - University of Sao Paulo

Sao Paulo, Brazil

Rosario Hirata

21

Center for Pharmacogenomics – The Ohio State University

Columbus, USA

Wolfgang Sadee

5

CANSEARCH research Laboratory

Geneva, Switzerland

Marc Ansari

16

 

 

TOTAL

125


Discussions are ongoing with:

 

Name

Location

 Contact

Omics Science Center – RIKEN Yokohama Institute

Yokohama, Japan

Toshihisa Ishikawa

Luxembourg Centre for Systems Medicine

Luxembourg

Jochen Schneider

Paris Team

Pharmacogénomique des anticoagulants

France

Marie-Anne Loriot/ Virginie Siguret / Pascale Gaussem

Charles Auffray

Lyon, France

Maria Nogueira

Leiden Academic Centre for Drug Research - Leiden University Medical Center

Leiden, The Netherlands

H.J. Guchelaar/J.J. Swen

Slovakian Research Group

Slovakia

Ivan Tkac

IKP Stuttgart – Institut für Klinische Pharmakologie

Stuttgart

Germany

Matthias Schwab

Institute for Pharmacology and Toxicology Center for Pharmacogenetics and Pharmacogenomics - Paracelsus Medical University

Salzburg, Austria

Markus Paulmichl

Centre Energie Atomique - Saclay

Gif sur Yvette

France

(Isabelle Philippe)

Department of Molecular and Clinical Pharmacology – The Wolfson Centre for Personalised Medicine – Institute of Translational Medicine – University of Liverpool

Liverpool, United Kingdom

Munir Pirmohamed

Department of Neurosciences, Mental Health and Sensory Organs - Sapienza University of Rome

Rome, Italy

Maurizio Simmaco